KLYG — Kelyniam Global Share Price
Last trade - 00:00- $5.67m
- $5.96m
- $0.20m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 17.11 | ||
| Price to Tang. Book | 19.73 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 26.28 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -33.68% | ||
| Return on Equity | -45.64% | ||
| Operating Margin | -104.22% | ||
Financial Summary
| Year End 31st Dec | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011E | 2012E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.07 | 0.05 | 0.45 | 0.27 | 0.2 | n/a | n/a | 30.65% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Kelyniam Global, Inc. is a custom design-to-build medical device manufacturing company specializing in the delivery of cranial implant technologies to neurologically dependent patients. The Company is engaged in the production of custom prosthetics utilizing computer-aided design and computer-aided manufacturing of medical-grade polymers. Its Engineering Division uses Bio-Computer Aided Design (CAD) Computer Aided Manufacturing (CAM) technology to provide replicated cranial implants to replace damaged bone structures. Its product, PEEK-Optima, is engineered for biocompatibility. Derived from the patient’s computed tomography (CT) data, its 3D BIO-CAD/CAM software is used to transfer the details found on the edge of the defect directly to the implant edge. Its emergency plan, ke24, provides precision-replicated, patient-specific cranial implants in approximately 24 hours. It distributes its products throughout the United States via independent distributors and sales representatives.
Directors
- Ross Bjella CHM (56)
- Terrance Kurtenbach CFO
- Christopher Breault COO
- Mark Chenoweth VPR
- Mark Smith VPR
- Nick Breault VPR
- James Barrow GCN
- Christopher Mirucki OTH
- Last Annual
- December 31st, 2010
- Last Interim
- June 30th, 2012
- Incorporated
- December 30th, 2005
- Public Since
- April 3rd, 2008
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 30,698,145
- Address
- 97 River Rd, COLLINSVILLE, 06019-3246
- Web
- https://kelyniam.com/
- Phone
- +1 8002808192
- Auditors
- Malone & Bailey, PLLC
Upcoming Events for KLYG
Similar to KLYG
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
Acutus Medical
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
FAQ
As of Today at 21:33 UTC, shares in Kelyniam Global are trading at $0.18. This share price information is delayed by 15 minutes.
Shares in Kelyniam Global last closed at $0.18 and the price had moved by +329.77% over the past 365 days. In terms of relative price strength the Kelyniam Global share price has outperformed the S&P500 Index by +298.51% over the past year.
There is no consensus recommendation for this security.
Find out moreKelyniam Global does not currently pay a dividend.
Kelyniam Global does not currently pay a dividend.
Kelyniam Global does not currently pay a dividend.
To buy shares in Kelyniam Global you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.18, shares in Kelyniam Global had a market capitalisation of $5.67m.
Here are the trading details for Kelyniam Global:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: KLYG
Based on an overall assessment of its quality, value and momentum Kelyniam Global is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kelyniam Global. Over the past six months, its share price has outperformed the S&P500 Index by +29.35%.
As of the last closing price of $0.18, shares in Kelyniam Global were trading +33.3% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Kelyniam Global PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.18.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Kelyniam Global's management team is headed by:
- Ross Bjella - CHM
- Terrance Kurtenbach - CFO
- Christopher Breault - COO
- Mark Chenoweth - VPR
- Mark Smith - VPR
- Nick Breault - VPR
- James Barrow - GCN
- Christopher Mirucki - OTH